Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

[1]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[2]  S. Coughlin,et al.  Burden of potentially human papillomavirus‐associated cancers of the oropharynx and oral cavity in the US, 1998–2003 , 2008, Cancer.

[3]  W. Westra,et al.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.

[4]  J. Pintos,et al.  Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. , 2008, Oral oncology.

[5]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[6]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[7]  E. Taioli,et al.  Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis , 2007, International journal of cancer.

[8]  E. Sturgis,et al.  Trends in head and neck cancer incidence in relation to smoking prevalence , 2007, Cancer.

[9]  A. Williamson,et al.  Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia , 2007, Journal of medical virology.

[10]  L. Turek,et al.  Prevalence of Human Papillomavirus in the Oral Cavity/Oropharynx in a Large Population of Children and Adolescents , 2007, The Pediatric infectious disease journal.

[11]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[12]  K. Anastos,et al.  Six‐month natural history of oral versus cervical human papillomavirus infection , 2007, International journal of cancer.

[13]  Henry C Kitchener,et al.  Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial , 2007, The Lancet.

[14]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related (HPV-R) and unrelated (HPV-U) head and neck squamous cell carcinomas (HNSCC) in the United States (US) , 2007 .

[15]  K. Kelsey,et al.  Human papillomavirus 16 and head and neck squamous cell carcinoma , 2007, International journal of cancer.

[16]  F. X. Bosch,et al.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions , 2007 .

[17]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[18]  Sylvia M Golas.  Trends in palatine tonsillar cancer incidence and mortality rates in the United States. , 2007, Community dentistry and oral epidemiology.

[19]  B. Rose,et al.  New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis , 2007, Pathology.

[20]  Per Brandtzaeg,et al.  Do Salivary Antibodies Reliably Reflect Both Mucosal and Systemic Immunity? , 2007, Annals of the New York Academy of Sciences.

[21]  Eduardo Lazcano-Ponce,et al.  Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents: A Randomized Controlled Trial , 2007, The Pediatric infectious disease journal.

[22]  M. Pawlita,et al.  Human papillomavirus seropositivity and risks of head and neck cancer , 2007, International journal of cancer.

[23]  D. Lindquist,et al.  The incidence of tonsillar cancer in Sweden is increasing , 2007, Acta oto-laryngologica.

[24]  E. Sugar,et al.  Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women , 2006, Journal of Clinical Microbiology.

[25]  B. Rose,et al.  Human papillomavirus in the oral cavity of patients with and without renal transplantation. , 2006, Transplantation.

[26]  D. Lowy,et al.  Chapter 12: Prophylactic HPV vaccines: underlying mechanisms. , 2006, Vaccine.

[27]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[28]  M. Gillison,et al.  Clinical implications of human papillomavirus in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  E. Rybicki,et al.  More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population , 2006, BMC infectious diseases.

[30]  L. Villa,et al.  The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population , 2006, Journal of medical virology.

[31]  S. Witkin,et al.  Human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[32]  J. Hughes,et al.  Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university women. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[33]  R. Ingham,et al.  Oral sex and condom use among young people in the United Kingdom. , 2006, Perspectives on sexual and reproductive health.

[34]  Jeanne M. Poduska,et al.  Predictors of Early Initiation of Vaginal and Oral Sex Among Urban Young Adults in Baltimore, Maryland , 2006, Archives of sexual behavior.

[35]  K. Ault.  Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract , 2006, Infectious diseases in obstetrics and gynecology.

[36]  Trends in HIV-related risk behaviors among high school students--United States, 1991-2005. , 2006, MMWR. Morbidity and mortality weekly report.

[37]  William D Mosher,et al.  Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. , 2005, Advance data.

[38]  B. Halpern-Felsher,et al.  Oral Versus Vaginal Sex Among Adolescents: Perceptions, Attitudes, and Behavior , 2005, Pediatrics.

[39]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[40]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[41]  B. Hansson,et al.  Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden , 2005, Acta oto-laryngologica.

[42]  Stina Syrj.  Human papillomavirus (HPV) in head and neck cancer , 2005 .

[43]  M. Gillison,et al.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.

[44]  C. R. Leemans,et al.  Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. , 2004, Journal of the National Cancer Institute.

[45]  S. Syrjänen.  HPV infections and tonsillar carcinoma , 2004, Journal of Clinical Pathology.

[46]  L. Turek,et al.  Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers , 2004, International journal of cancer.

[47]  K. Shah,et al.  Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. , 2004, The Journal of infectious diseases.

[48]  M. Sherman,et al.  Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection , 2004, Cancer Epidemiology Biomarkers & Prevention.

[49]  L. Turek,et al.  Human Papillomavirus Prevalence and Types in Newborns and Parents: Concordance and Modes of Transmission , 2004, Sexually transmitted diseases.

[50]  L. Turek,et al.  Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. , 2003, Journal of the National Cancer Institute.

[51]  R. Biggar,et al.  Changing patterns of tonsillar squamous cell carcinoma in the United States , 2000, Cancer Causes & Control.

[52]  S. Franceschi,et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.

[53]  W. Dinjens,et al.  A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8 , 2003, International journal of cancer.

[54]  P. Fuchs,et al.  Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? , 2003, Medical Microbiology and Immunology.

[55]  M. Spitz,et al.  Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  Geoffrey L. Cohen,et al.  Adolescent oral sex, peer popularity, and perceptions of best friends' sexual behavior. , 2003, Journal of pediatric psychology.

[57]  M. Hagensee,et al.  Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals , 2003, Clinical Diagnostic Laboratory Immunology.

[58]  L. Turek,et al.  Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx , 2003, International journal of cancer.

[59]  C. Rissel,et al.  Sex in Australia: First experiences of vaginal intercourse and oral sex among a representative sample of adults , 2003, Australian and New Zealand journal of public health.

[60]  K. Shah,et al.  Condyloma in Pregnancy Is Strongly Predictive of Juvenile‐Onset Recurrent Respiratory Papillomatosis , 2003, Obstetrics and gynecology.

[61]  Iver Petersen,et al.  Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. , 2003, Cancer research.

[62]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[63]  J. Lindholm,et al.  Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer , 2002, International journal of cancer.

[64]  K. Kelsey,et al.  Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[65]  S. Soltys,et al.  Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma , 2002, Head & neck.

[66]  J. Califano,et al.  Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[67]  A. Weaver,et al.  Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  F. Bosch,et al.  Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.

[69]  R. Tindle.  Immune evasion in human papillomavirus-associated cervical cancer , 2002, Nature Reviews Cancer.

[70]  H. Dienes,et al.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas , 2001, Cancer.

[71]  J. Best,et al.  Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia , 2001, Journal of medical virology.

[72]  J. Sabio,et al.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.

[73]  G. Snow,et al.  Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas , 2001, International journal of cancer.

[74]  R. Lewensohn,et al.  Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival , 2000, International journal of cancer.

[75]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[76]  S. Syrjänen,et al.  Human papillomavirus infections in children: the potential role of maternal transmission. , 2000, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[77]  G. Clayman,et al.  Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. , 1999, Oral oncology.

[78]  J. Dillner,et al.  High risk genital papillomavirus infections are not spread vertically , 1999, Reviews in medical virology.

[79]  J. Best,et al.  High risk genital papillomavirus infections are spread vertically , 1999, Reviews in medical virology.

[80]  S. Schwartz,et al.  Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.

[81]  L. Turek,et al.  Human papillomavirus and risk of oral cancer , 1998, The Laryngoscope.

[82]  C. Carne,et al.  Oral sex and transmission of non-viral STIs. , 1998, Sexually transmitted infections.

[83]  K. Holmes,et al.  Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. , 1998, American journal of obstetrics and gynecology.

[84]  C. Carne,et al.  Oral sex and the transmission of viral STIs. , 1998, Sexually transmitted infections.

[85]  S. Wilczynski,et al.  Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. , 1998, The American journal of pathology.

[86]  F. Bosch,et al.  Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. , 1998, Cancer research.

[87]  F. Coutlée,et al.  Risk Factors for Oral Human Papillomavirus in Adults Infected and Not Infected With Human Immunodeficiency Virus , 1997, Sexually transmitted diseases.

[88]  S. Franceschi,et al.  Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[89]  G. Snow,et al.  Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. , 1996, European journal of cancer. Part B, Oral oncology.

[90]  R. Schlegel,et al.  Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  C. Meijer,et al.  Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. , 1995, Cancer research.

[92]  S. McCormack,et al.  Trends in female sexual behaviour and sexually transmitted diseases in London, 1982-1992. , 1995, Genitourinary medicine.

[93]  M B Oliver,et al.  Gender differences in sexuality: a meta-analysis. , 1993, Psychological bulletin.

[94]  G. Snow,et al.  Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology , 1992, International journal of cancer.

[95]  H. Stein,et al.  Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. , 1990, Journal of clinical pathology.

[96]  J. Gagnon,et al.  The sexual scripting of oral genital contacts , 1987, Archives of sexual behavior.

[97]  J. Becker,et al.  Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. , 1985, The Journal of investigative dermatology.

[98]  S. Syrjänen,et al.  Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. , 1983, International journal of oral surgery.